{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:20:17Z","timestamp":1789665617593,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejps.2024.106829","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T18:59:48Z","timestamp":1718045988000},"page":"106829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3786-0659","authenticated-orcid":false,"given":"Tianrong","family":"Xun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhufen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejps.2024.106829_bib0001","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bdd.2337","article-title":"In vitro-in vivo extrapolation of bexarotene metabolism in the presence of chronic kidney disease and acute kidney injury in rat using physiologically based pharmacokinetic modeling and extrapolation to human","volume":"44","author":"Alsmadi","year":"2023","journal-title":"Biopharm. Drug Dispos."},{"issue":"3","key":"10.1016\/j.ejps.2024.106829_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15030179","article-title":"Advanced oxidation protein products contribute to chronic-kidney-disease-induced adipose inflammation through macrophage activation","volume":"15","author":"Arimura","year":"2023","journal-title":"Toxins. (Basel)"},{"key":"10.1016\/j.ejps.2024.106829_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2021.06.008","article-title":"AOPPs induce HTR-8\/SVneo cell apoptosis by downregulating the Nrf-2\/ARE\/HO-1 anti-oxidative pathway: potential implications for preeclampsia","volume":"112","author":"Chen","year":"2021","journal-title":"Placenta"},{"issue":"10","key":"10.1016\/j.ejps.2024.106829_bib0004","doi-asserted-by":"crossref","first-page":"13300","DOI":"10.1096\/fj.202000783R","article-title":"FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury","volume":"34","author":"Chen","year":"2020","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.ejps.2024.106829_bib0005","doi-asserted-by":"crossref","first-page":"38534","DOI":"10.3390\/molecules27238534","article-title":"Paeoniflorin protects against acetaminophen induced liver injury in mice via JNK signaling pathway","volume":"27","author":"Deng","year":"2022","journal-title":"Molecules"},{"issue":"15","key":"10.1016\/j.ejps.2024.106829_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153711","article-title":"Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling Ariadne's thread","volume":"20","author":"Duni","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejps.2024.106829_bib0007","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: an update","volume":"94","author":"Garcia-Cortes","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejps.2024.106829_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109056","article-title":"Cytochrome P450 2E1 and its roles in disease","volume":"322","author":"Guengerich","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.ejps.2024.106829_bib0009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1039\/C7TX00020K","article-title":"Toxicological implications of mitochondrial localization of CYP2E1","volume":"6","author":"Hartman","year":"2017","journal-title":"Toxicol. Res. (Camb)"},{"issue":"10302","key":"10.1016\/j.ejps.2024.106829_bib0010","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2024.106829_bib0011","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ackd.2015.10.002","article-title":"The effects of CKD on cytochrome P450-mediated drug metabolism","volume":"23","author":"Ladda","year":"2016","journal-title":"Adv. Chronic. Kidney Dis."},{"issue":"2","key":"10.1016\/j.ejps.2024.106829_bib0012","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1681\/ASN.2006070781","article-title":"Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model","volume":"18","author":"Li","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.ejps.2024.106829_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13020142","article-title":"Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets","volume":"13","author":"Lim","year":"2021","journal-title":"Toxins. (Basel)"},{"issue":"7","key":"10.1016\/j.ejps.2024.106829_bib0014","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2174\/1389200219666180103143448","article-title":"Metabolic enzyme system and transport pathways in chronic kidney diseases","volume":"19","author":"Liu","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2024.106829_bib0015","article-title":"Creatinine accelerates APAP-induced liver damage by increasing oxidative stress through ROS\/JNK signaling pathway","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2024.106829_bib0016","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12974-020-01751-2","article-title":"Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-\u03baB signaling pathway and pyroptosis after secondary spinal cord injury","volume":"17","author":"Liu","year":"2020","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.ejps.2024.106829_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110219","article-title":"Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation","volume":"368","author":"Lu","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.ejps.2024.106829_bib0018","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","article-title":"CYP2E1 and oxidative liver injury by alcohol","volume":"44","author":"Lu","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.ejps.2024.106829_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10060226","article-title":"Uremic toxin clearance and cardiovascular toxicities","volume":"10","author":"Mair","year":"2018","journal-title":"Toxins. (Basel)"},{"key":"10.1016\/j.ejps.2024.106829_bib0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1248\/yakushi.20-00010","article-title":"Is concomitant therapy with acetaminophen and low-dose aspirin a risk factor for CKD progression? a 6-year cohort study","volume":"140","author":"Mitsuboshi","year":"2020","journal-title":"Yakugaku Zasshi"},{"issue":"9","key":"10.1016\/j.ejps.2024.106829_bib0021","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jama.2023.1080","article-title":"Association of FDA mandate limiting acetaminophen (paracetamol) in prescription combination opioid products and subsequent hospitalizations and acute liver failure","volume":"329","author":"Orandi","year":"2023","journal-title":"JAMa"},{"issue":"11","key":"10.1016\/j.ejps.2024.106829_bib0022","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1007\/s12035-021-02493-9","article-title":"Advanced oxidative protein products role in multiple sclerosis: a systematic review and meta-analysis","volume":"58","author":"Rodrigues","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.ejps.2024.106829_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11040209","article-title":"Emerging roles of aryl hydrocarbon receptors in the altered clearance of drugs during chronic kidney disease","volume":"11","author":"Santana Machado","year":"2019","journal-title":"Toxins. (Basel)"},{"issue":"6","key":"10.1016\/j.ejps.2024.106829_bib0024","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ddr.21971","article-title":"Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors","volume":"83","author":"Singh","year":"2022","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.ejps.2024.106829_bib0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40266-020-00747-0","article-title":"Adverse drug events in patients with chronic kidney disease associated with multiple drug interactions and polypharmacy","volume":"37","author":"Sommer","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejps.2024.106829_bib0026","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.redox.2014.11.004","article-title":"CYP2E1 autoantibodies in liver diseases","volume":"3","author":"Sutti","year":"2014","journal-title":"Redox. Biol."},{"key":"10.1016\/j.ejps.2024.106829_bib0027","article-title":"Circulating cell-free dnas as a biomarker and therapeutic target for acetaminophen-induced liver injury","volume":"10","author":"Sun","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.ejps.2024.106829_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010015","article-title":"Treatment of drug-induced liver injury","volume":"11","author":"Teschke","year":"2022","journal-title":"Biomedicines."},{"key":"10.1016\/j.ejps.2024.106829_bib0030","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1248\/bpb.b20-00124","article-title":"Effect of chronic kidney disease on hepatic clearance of drugs in rats","volume":"43","author":"Tokunaga","year":"2020","journal-title":"Biol. Pharm. Bull"},{"issue":"3","key":"10.1016\/j.ejps.2024.106829_bib0031","article-title":"Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice","volume":"10","author":"Villanueva-Paz","year":"2021","journal-title":"Antioxidants. (Basel)"},{"issue":"6","key":"10.1016\/j.ejps.2024.106829_bib0032","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1159\/000356619","article-title":"AOPPs induce MCP-1 expression by increasing ROS-mediated activation of the NF-\u03baB pathway in rat mesangial cells: inhibition by sesquiterpene lactones","volume":"32","author":"Wang","year":"2013","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.ejps.2024.106829_bib0033","article-title":"peroxiredoxin 3 inhibits acetaminophen-induced liver pyroptosis through the regulation of mitochondrial ROS","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2024.106829_bib0034","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.161.5.2524","article-title":"Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure","volume":"161","author":"Witko-Sarsat","year":"1998","journal-title":"J. Immunol"},{"key":"10.1016\/j.ejps.2024.106829_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105342","article-title":"Advanced oxidation protein products upregulate efflux transporter expression and activity through activation of the Nrf-2-mediated signaling pathway in vitro and in vivo","volume":"149","author":"Xun","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106829_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116140","article-title":"Advanced oxidation protein products upregulate ABCB1 expression and activity via HDAC2-Foxo3\u03b1-mediated signaling in vitro and in vivo","volume":"449","author":"Xun","year":"2022","journal-title":"Toxicol. Appl. Pharmacol"},{"issue":"22","key":"10.1016\/j.ejps.2024.106829_bib0036","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1002\/cam4.4320","article-title":"Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas","volume":"10","author":"Ye","year":"2021","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.ejps.2024.106829_bib0037","doi-asserted-by":"crossref","first-page":"e13098","DOI":"10.1111\/eci.13098","article-title":"Advanced oxidation protein products play critical roles in liver diseases","volume":"49","author":"Zhao","year":"2019","journal-title":"Eur. J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ejps.2024.106829_bib0038","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2022.10.066","article-title":"Effect of advanced oxidation protein products (AOPPs) and aging on the osteoclast differentiation of myeloid-derived suppressor cells (MDSCs) and its preliminary mechanism","volume":"636","author":"Zou","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T02:45:17Z","timestamp":1721961917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"alternative-id":["S0928098724001416"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106829","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106829"}}